Principal Financial Group Inc. Buys 7,616 Shares of Oscar Health, Inc. (NYSE:OSCR)

Principal Financial Group Inc. boosted its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 40.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,266 shares of the company’s stock after purchasing an additional 7,616 shares during the period. Principal Financial Group Inc.’s holdings in Oscar Health were worth $416,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. American International Group Inc. lifted its stake in Oscar Health by 1.3% in the 1st quarter. American International Group Inc. now owns 79,411 shares of the company’s stock valued at $1,181,000 after acquiring an additional 1,009 shares in the last quarter. ProShare Advisors LLC lifted its position in shares of Oscar Health by 10.9% in the first quarter. ProShare Advisors LLC now owns 28,950 shares of the company’s stock worth $430,000 after purchasing an additional 2,842 shares in the last quarter. Oppenheimer & Co. Inc. boosted its holdings in Oscar Health by 20.8% during the first quarter. Oppenheimer & Co. Inc. now owns 19,450 shares of the company’s stock worth $289,000 after purchasing an additional 3,350 shares during the last quarter. Avalon Trust Co bought a new position in Oscar Health in the first quarter valued at $69,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Oscar Health by 26.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,210 shares of the company’s stock valued at $383,000 after buying an additional 5,138 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Stock Up 2.9 %

OSCR stock opened at $21.61 on Friday. Oscar Health, Inc. has a 1-year low of $4.72 and a 1-year high of $23.44. The business’s 50 day simple moving average is $17.27 and its 200 day simple moving average is $17.33. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $5.23 billion, a PE ratio of -54.02, a PEG ratio of 40.95 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last posted its earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company had revenue of $2.20 billion during the quarter, compared to analysts’ expectations of $2.13 billion. During the same quarter last year, the company posted ($0.07) EPS. Oscar Health’s quarterly revenue was up 44.6% compared to the same quarter last year. As a group, research analysts anticipate that Oscar Health, Inc. will post 0.01 EPS for the current year.

Insider Transactions at Oscar Health

In related news, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the sale, the insider now directly owns 76,982 shares of the company’s stock, valued at approximately $1,384,906.18. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, insider Mario Schlosser sold 3,198 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the transaction, the insider now directly owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Victoria Baltrus sold 4,226 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $76,025.74. Following the completion of the sale, the chief accounting officer now owns 140,648 shares of the company’s stock, valued at $2,530,257.52. The disclosure for this sale can be found here. Insiders sold a total of 169,569 shares of company stock worth $3,007,069 over the last quarter. Company insiders own 25.11% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently commented on OSCR. Piper Sandler restated an “overweight” rating and set a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. Baird R W upgraded Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Bank of America reiterated a “neutral” rating and set a $21.00 price objective (down previously from $25.00) on shares of Oscar Health in a research note on Thursday, May 30th. Wells Fargo & Company increased their price objective on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a report on Wednesday, June 12th. Finally, Robert W. Baird began coverage on shares of Oscar Health in a report on Thursday, May 30th. They set an “outperform” rating and a $28.00 target price on the stock. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $24.17.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.